Didier Bénard

Title: The Innovations of Didier Bénard

Introduction

Didier Bénard is a notable inventor based in Attainville, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of 2 patents to his name, Bénard's work is focused on innovative compounds that have the potential to treat serious medical conditions.

Latest Patents

Bénard's latest patents include groundbreaking work on cyclic urea compounds. The first patent, titled "Cyclic urea compounds, preparation thereof and pharmaceutical use thereof as kinase inhibitors," describes a cyclic urea compound that can inhibit protein kinase activity. This compound is particularly useful for preventing or treating physiological disorders, such as solid tumors. The second patent, "Cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors," further explores similar compounds and their pharmaceutical applications. Both patents emphasize the importance of these compounds in modulating the activity of protein kinases.

Career Highlights

Didier Bénard is currently associated with Aventis Pharma S.A., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and application of kinase inhibitors in medical treatments.

Collaborations

Bénard has collaborated with notable colleagues, including Marcel Patek and Anil Nair. These partnerships have contributed to the successful development of his patented compounds.

Conclusion

Didier Bénard's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work on cyclic urea compounds showcases the potential for new treatments in combating serious health issues.